We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
19
quarters
Top 20 Avg Time Held
14.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1576
USA Today Co
TDAY
$998M
| $96.5K | ﹤0.01% |
13,681
+1,691
| +14% | +$10.4K |
2024 Q4
5 quarters
|
|
1577
Nuvation Bio
NUVB
$1.74B
| $94.5K | ﹤0.01% |
22,035
+3,079
| +16% | +$17.2K |
2024 Q2
7 quarters
|
|
1578
United States Antimony
UAMY
$521M
| $94.2K | ﹤0.01% |
+10,793
| New | +$94.1K |
2026 Q1
0 quarters
|
|
1579
Harmonic Inc
HLIT
$1.16B
| $92K | ﹤0.01% |
+10,243
| New | +$102K |
2026 Q1
0 quarters
|
|
1580
Bitdeer Technologies
BTDR
$2.52B
| $90.3K | ﹤0.01% |
+10,441
| New | +$110K |
2026 Q1
0 quarters
|
|
1581
Taysha Gene Therapies
TSHA
$1.42B
| $89.5K | ﹤0.01% |
20,033
+2,815
| +16% | +$13.1K |
2024 Q3
6 quarters
|
|
1582
Wave Life Sciences
WVE
$664M
| $89.2K | ﹤0.01% |
+12,303
| New | +$160K |
2026 Q1
0 quarters
|
|
1583
Genius Sports
GENI
$1.75B
| $87.8K | ﹤0.01% |
19,817
+2,793
| +16% | +$19.9K |
2025 Q2
3 quarters
|
|
1584
Enovix
ENVX
$553M
| $87.8K | ﹤0.01% |
16,942
+3,810
| +29% | +$23.8K |
2024 Q3
6 quarters
|
|
1585
Teladoc Health
TDOC
$1.04B
| $87.5K | ﹤0.01% |
16,053
+1,865
| +13% | +$10.5K |
2024 Q2
7 quarters
|
|
1586
NeoGenomics
NEO
$2.1B
| $87.3K | ﹤0.01% |
11,764
+1,647
| +16% | +$17.3K |
2025 Q2
3 quarters
|
|
1587
RLJ Lodging Trust
RLJ
$1.72B
| $85.9K | ﹤0.01% |
11,571
+801
| +7% | +$6.23K |
2024 Q4
5 quarters
|
|
1588
Biohaven
BHVN
$1.78B
| $85.2K | ﹤0.01% |
+10,069
| New | +$110K |
2026 Q1
0 quarters
|
|
1589
Coty
COTY
$2.53B
| $85K | ﹤0.01% |
42,288
+7,286
| +21% | +$19.6K |
2020 Q2
23 quarters
|
|
1590
Piedmont Realty Trust
PDM
$1.13B
| $84.1K | ﹤0.01% |
12,795
+1,491
| +13% | +$11.6K |
2024 Q4
5 quarters
|
|
1591
Evolv Technologies
EVLV
$808M
| $83.8K | ﹤0.01% |
13,846
+1,862
| +16% | +$10.9K |
2025 Q4
1 quarter
|
|
1592
Burford Capital
BUR
$786M
| $83.4K | ﹤0.01% |
18,454
+2,646
| +17% | +$23.1K |
2024 Q2
7 quarters
|
|
1593
Xeris Biopharma Holdings
XERS
$1.92B
| $83.1K | ﹤0.01% |
14,325
+2,213
| +18% | +$14.7K |
2025 Q1
4 quarters
|
|
1594
NCR Voyix
VYX
$961M
| $80.3K | ﹤0.01% |
12,693
+1,628
| +15% | +$14.4K |
2024 Q4
5 quarters
|
|
1595
Capitol Federal Financial
CFFN
$1.04B
| $79.7K | ﹤0.01% |
+11,173
| New | +$79.6K |
2026 Q1
0 quarters
|
|
1596
Acco Brands
ACCO
$414M
| $79.1K | ﹤0.01% |
26,383
+1,048
| +4% | +$3.95K |
2024 Q4
5 quarters
|
|
1597
Under Armour
UAA
$2.11B
| $78.9K | ﹤0.01% |
+13,345
| New | +$86.5K |
2026 Q1
0 quarters
|
|
1598
Under Armour Class C
UA
$2.05B
| $76.1K | ﹤0.01% |
+13,140
| New | +$82.9K |
2026 Q1
0 quarters
|
|
1599
Coursera
COUR
$1.34B
| $74.9K | ﹤0.01% |
12,862
+1,631
| +15% | +$10.2K |
2025 Q1
4 quarters
|
|
1600
T1 Energy
TE
$957M
| $73.9K | ﹤0.01% |
16,839
+6,474
| +62% | +$47.4K |
2025 Q4
1 quarter
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.